MUC16 and ovarian carcinoma: Biomarkers such as CA‐125 and HE4 remain central to ovarian cancer prediction, with their predictive accuracy further enhanced when combined with additional biomarkers such as CEA, CA72‐4, and inflammatory markers like CRP and NLR.